Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study hakki2022onset

This analyte represents the detection and quantification of SARS-CoV-2 viral RNA from throat and nose swabs specimens collected from asymptomatic participants. The analysis focuses on measuring the viral load expressed in log10 copies/mL, with the primary reference event being the enrollment.

The infectious virus analyte consisted of culturable SARS-CoV-2 derived from throat and nasal swabs of asymptomatic participants, measured using a plaque assay in vitro. The unit of measurement was PFU/mL, with enrollment as the primary reference event.

This analyte represents the detection and quantification of SARS-CoV-2 viral RNA from throat and nose swabs specimens collected from symptomatic participants. The analysis focuses on measuring the viral load expressed in log10 copies/mL, with the primary reference event being the symptom onset.

The infectious virus analyte consisted of culturable SARS-CoV-2 derived from throat and nasal swabs of symptomatic participants, measured using a plaque assay in vitro. The unit of measurement was PFU/mL, with symptom onset as the primary reference event.